ABVC

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

ABVC Biopharma Inc

NASDAQ | ABVC

2.61

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$65.86M

Market Cap

-

P/E Ratio

-0.28

EPS

$5.48

52 Week High

$0.40

52 Week Low

HEALTHCARE

Sector

ABVC Chart

Recent Chart
Price Action

ABVC Technicals

Tags:

ABVC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $509K
Total Revenue $510K
Cost Of Revenue $763
Costof Goods And Services Sold $763
Operating Income -$4.7M
Selling General And Administrative $5M
Research And Development $179K
Operating Expenses $5.2M
Investment Income Net -
Net Interest Income -$739K
Interest Income $87K
Interest Expense $826K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $201K
Income Before Tax -$5.4M
Income Tax Expense -$111K
Interest And Debt Expense -
Net Income From Continuing Operations -$5.3M
Comprehensive Income Net Of Tax -
Ebit -$4.5M
Ebitda -$4.3M
Net Income -$4.9M

Revenue & Profitability

Earnings Performance

ABVC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $7.5M
Total Current Assets $2.2M
Cash And Cash Equivalents At Carrying Value $864K
Cash And Short Term Investments $864K
Inventory -
Current Net Receivables $1.2M
Total Non Current Assets $5.4M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $2.3M
Short Term Investments $65K
Other Current Assets $96K
Other Non Current Assets -
Total Liabilities $6.8M
Total Current Liabilities $6.6M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt $3M
Total Non Current Liabilities $258K
Capital Lease Obligations $640K
Long Term Debt -
Current Long Term Debt $1.8M
Long Term Debt Noncurrent -
Short Long Term Debt Total $3.2M
Other Current Liabilities $3.5M
Other Non Current Liabilities $22K
Total Shareholder Equity $1.2M
Treasury Stock -
Retained Earnings -$69M
Common Stock $14K
Common Stock Shares Outstanding $12M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$1.8M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $201K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $2M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$7.3K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$5.3M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $509K
Total Revenue $510K
Cost Of Revenue $763
Costof Goods And Services Sold $763
Operating Income -$4.7M
Selling General And Administrative $5M
Research And Development $179K
Operating Expenses $5.2M
Investment Income Net -
Net Interest Income -$739K
Interest Income $87K
Interest Expense $826K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $201K
Income Before Tax -$5.4M
Income Tax Expense -$111K
Interest And Debt Expense -
Net Income From Continuing Operations -$5.3M
Comprehensive Income Net Of Tax -
Ebit -$4.5M
Ebitda -$4.3M
Net Income -$4.9M

ABVC News

ABVC Profile

ABVC Biopharma Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

ABVC Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies and medical devices that target significant unmet medical needs, primarily within the U.S. market. With a robust and diverse pipeline that encompasses both therapeutic agents and advanced drug delivery systems, ABVC is committed to improving patient outcomes across various disease indications. The company leverages cutting-edge technologies and strategic partnerships to enhance its development capabilities, positioning itself as a promising player in the biopharmaceutical sector with substantial growth potential and a commitment to impactful healthcare solutions.

LPTX
+368.57%
$2.05
DRCT
+3.38%
$0.11
PAVS
-92.57%
$0.07
BYND
+36.48%
$1.34
VHAI
0.00%
$0.00
NVDA
+1.64%
$179.92
KALA
+37.66%
$1.33
QTTB
+74.42%
$3.82
HBI
-1.82%
$6.47
BITF
-5.74%
$3.28
ASST
-6.25%
$1.05
IPG
-1.95%
$24.57
FTEL
+41.17%
$1.20
PLUG
-4.47%
$1.92
AAL
-0.64%
$13.96
INTC
-1.35%
$40.01
AXDX
-61.36%
$0.03
BMNR
-12.62%
$28.94
IVP
+3.78%
$0.12
NIO
-5.81%
$5.18
TSLA
0.00%
$430.14
TLRY
-3.76%
$0.78
PFE
-1.82%
$25.27
BURU
-8.63%
$0.22
CHR
+4.81%
$0.04
ADAP
-15.14%
$0.05
F
-0.90%
$13.16
ONDS
-4.05%
$7.58
NFE
+7.37%
$1.31
CLSK
-6.75%
$14.08
SOFI
-2.32%
$29.03
BTBT
-5.46%
$2.25
MARA
-2.45%
$11.52
BMNU
-24.98%
$6.14
AAPL
+1.52%
$283.10
AHMA
+198.12%
$14.34
RIVN
+1.77%
$17.16
SNAP
-0.52%
$7.64
SOND
-23.45%
$0.12
MSTR
-3.25%
$171.42
AMZN
+0.28%
$233.88
INHD
-22.06%
$0.17
YGMZ
-1.79%
$0.10
RMBL
+60.50%
$3.21
GOOGL
-1.65%
$314.89
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ACHR
-4.23%
$7.46
WBD
-0.54%
$23.87
CNEY
-9.96%
$1.31
CIFR
-3.24%
$19.69
BTG
-0.43%
$4.60
SRM
+53.27%
$10.30
RPGL
+5.72%
$0.42
T
-0.88%
$25.79
CAN
-6.15%
$0.94
EXK
-5.33%
$9.40
RIG
-1.36%
$4.35
DNN
-1.56%
$2.52
HOOD
-4.08%
$123.24
AMD
+1.02%
$219.76
GRAB
-3.30%
$5.27
BBD
-2.16%
$3.62
WULF
-1.35%
$15.30
RGTI
-8.29%
$23.45
BAC
-0.76%
$53.24
WLGS
-5.57%
$0.04
GOOG
-1.56%
$315.12
MTSR
-0.35%
$70.50
HBAN
+1.47%
$16.54
PLTR
-0.56%
$167.49
KVUE
-0.74%
$17.22
AG
+1.90%
$15.52
PLTD
+0.71%
$7.09
HPE
+0.32%
$21.94
CRWV
+5.38%
$77.06
APLD
+4.09%
$28.21
HL
+1.66%
$17.10
ITUB
-1.41%
$7.69
NFLX
+1.44%
$109.13
AFMD
-34.94%
$0.18
VALE
+0.63%
$12.69
PRPH
-7.51%
$0.19
CPNG
-5.36%
$26.65
MSFT
-1.07%
$486.74
SOUN
-4.39%
$11.52
AVGO
-4.18%
$386.08
RUBI
-13.53%
$0.13
AGNC
-0.28%
$10.46
IREN
+1.42%
$48.49
SMCI
-1.29%
$33.41
SMR
-9.60%
$18.08
CDE
-1.79%
$16.96
BTE
0.00%
$3.22
TE
+8.49%
$4.47
TSLG
+0.10%
$9.27
VZ
-0.90%
$40.74
AUR
-4.77%
$3.99
ALIT
+3.89%
$2.36
NCT
-26.87%
$0.56
LPTX
+368.57%
$2.05
DRCT
+3.38%
$0.11
PAVS
-92.57%
$0.07
BYND
+36.48%
$1.34
VHAI
0.00%
$0.00
NVDA
+1.64%
$179.92
KALA
+37.66%
$1.33
QTTB
+74.42%
$3.82
HBI
-1.82%
$6.47
BITF
-5.74%
$3.28
ASST
-6.25%
$1.05
IPG
-1.95%
$24.57
FTEL
+41.17%
$1.20
PLUG
-4.47%
$1.92
AAL
-0.64%
$13.96
INTC
-1.35%
$40.01
AXDX
-61.36%
$0.03
BMNR
-12.62%
$28.94
IVP
+3.78%
$0.12
NIO
-5.81%
$5.18
TSLA
0.00%
$430.14
TLRY
-3.76%
$0.78
PFE
-1.82%
$25.27
BURU
-8.63%
$0.22
CHR
+4.81%
$0.04
ADAP
-15.14%
$0.05
F
-0.90%
$13.16
ONDS
-4.05%
$7.58
NFE
+7.37%
$1.31
CLSK
-6.75%
$14.08
SOFI
-2.32%
$29.03
BTBT
-5.46%
$2.25
MARA
-2.45%
$11.52
BMNU
-24.98%
$6.14
AAPL
+1.52%
$283.10
AHMA
+198.12%
$14.34
RIVN
+1.77%
$17.16
SNAP
-0.52%
$7.64
SOND
-23.45%
$0.12
MSTR
-3.25%
$171.42
AMZN
+0.28%
$233.88
INHD
-22.06%
$0.17
YGMZ
-1.79%
$0.10
RMBL
+60.50%
$3.21
GOOGL
-1.65%
$314.89
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ACHR
-4.23%
$7.46
WBD
-0.54%
$23.87
CNEY
-9.96%
$1.31
CIFR
-3.24%
$19.69
BTG
-0.43%
$4.60
SRM
+53.27%
$10.30
RPGL
+5.72%
$0.42
T
-0.88%
$25.79
CAN
-6.15%
$0.94
EXK
-5.33%
$9.40
RIG
-1.36%
$4.35
DNN
-1.56%
$2.52
HOOD
-4.08%
$123.24
AMD
+1.02%
$219.76
GRAB
-3.30%
$5.27
BBD
-2.16%
$3.62
WULF
-1.35%
$15.30
RGTI
-8.29%
$23.45
BAC
-0.76%
$53.24
WLGS
-5.57%
$0.04
GOOG
-1.56%
$315.12
MTSR
-0.35%
$70.50
HBAN
+1.47%
$16.54
PLTR
-0.56%
$167.49
KVUE
-0.74%
$17.22
AG
+1.90%
$15.52
PLTD
+0.71%
$7.09
HPE
+0.32%
$21.94
CRWV
+5.38%
$77.06
APLD
+4.09%
$28.21
HL
+1.66%
$17.10
ITUB
-1.41%
$7.69
NFLX
+1.44%
$109.13
AFMD
-34.94%
$0.18
VALE
+0.63%
$12.69
PRPH
-7.51%
$0.19
CPNG
-5.36%
$26.65
MSFT
-1.07%
$486.74
SOUN
-4.39%
$11.52
AVGO
-4.18%
$386.08
RUBI
-13.53%
$0.13
AGNC
-0.28%
$10.46
IREN
+1.42%
$48.49
SMCI
-1.29%
$33.41
SMR
-9.60%
$18.08
CDE
-1.79%
$16.96
BTE
0.00%
$3.22
TE
+8.49%
$4.47
TSLG
+0.10%
$9.27
VZ
-0.90%
$40.74
AUR
-4.77%
$3.99
ALIT
+3.89%
$2.36
NCT
-26.87%
$0.56
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.